.
MergerLinks Header Logo

New Deal


Announced

Dechra to acquire Ampharmco for $30m.

Financials

Edit Data
Transaction Value£24m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Acquisition

Pending

veterinary products

Pharmaceuticals

Private

Friendly

United States

Single Bidder

Synopsis

Edit

Dechra, an England-based manufacturer of veterinary products, agreed to acquire Ampharmco, a veterinary contract manufacturer specialising in companion animal products, for $30m. Ian Page, Dechra's Chief Executive Officer commented: "We are pleased to have completed the acquisition of APC which allows us to bring in-house manufacturing for a number of our currently outsourced products in the US market and will, in the longer term, also add to our US portfolio of approved CAP products."

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US